Imaging in its Heyday: Research Applications (Part 1)
Biomolecular imaging is upgrading diagnostic imaging's stodgy reputation as scientists increasingly use it to improve both pharmaceutical research and clinical care. Part I of a two-part series explores researchers' excitement about biomolecular imaging's potential to improve the drug development process. Many companies see research applications as a way to prime the marketplace for clinical applications. But venture capitalists think research is a limited opportunity.
By Wendy Diller
Looking for early evidence that its key cancer drug imatinib mesylate (Gleevec) was effective in patients with inoperable gastrointestinal stromal...
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Medtech Insight for daily insights